BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marzano AV, Cugno M, Trevisan V, Fanoni D, Venegoni L, Berti E, Crosti C. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol. 2010;162:100-107. [PMID: 20636397 DOI: 10.1111/j.1365-2249.2010.04201.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 86] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Lima AL, Karl I, Giner T, Poppe H, Schmidt M, Presser D, Goebeler M, Bauer B. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol. 2016;174:514-521. [PMID: 26436522 DOI: 10.1111/bjd.14214] [Cited by in Crossref: 111] [Cited by in F6Publishing: 93] [Article Influence: 18.5] [Reference Citation Analysis]
2 Park KS, Min Y, Park SR, Kim EH, Lee DJ, Bang D, Lee E. Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease. Tissue Antigens 2012;79:333-9. [DOI: 10.1111/j.1399-0039.2012.01863.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
3 Vaidy K, Winderman R, Rabinowitz SS, Schwarz SM. Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease. JPGN Reports 2020;1:e008. [DOI: 10.1097/pg9.0000000000000008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nakanishi K, Kinjo M. Mimicker of necrotising fasciitis with systemic inflammatory response syndrome: recurrent necrotising Sweet's syndrome associated with chronic myelogenous leukaemia. BMJ Case Rep 2016;2016:bcr2016214461. [PMID: 27033292 DOI: 10.1136/bcr-2016-214461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol. 2017;176:1588-1598. [PMID: 27943240 DOI: 10.1111/bjd.15226] [Cited by in Crossref: 101] [Cited by in F6Publishing: 71] [Article Influence: 25.3] [Reference Citation Analysis]
6 Marzano AV, Tedeschi A, Menicanti C, Asero R, Crosti C, Cugno M. Chronic Spontaneous Urticaria: the Emerging Role of Coagulation. Curr Derm Rep 2013;2:18-23. [DOI: 10.1007/s13671-012-0036-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Maglie R, Genovese G, Solimani F, Guglielmo A, Pileri A, Portelli F, Hertl M, Marzano AV, Antiga E. Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review. Am J Clin Dermatol 2020;21:833-54. [PMID: 32813229 DOI: 10.1007/s40257-020-00553-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
8 Ahn C, Negus D, Huang W. Pyoderma gangrenosum: a review of pathogenesis and treatment. Expert Rev Clin Immunol 2018;14:225-33. [PMID: 29406827 DOI: 10.1080/1744666X.2018.1438269] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 13.7] [Reference Citation Analysis]
9 Garzorz N, Papanagiotou V, Atenhan A, Andres C, Eyerich S, Eyerich K, Ring J, Brockow K. Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes? J Eur Acad Dermatol Venereol. 2014;Jul 28; Epub ahead of print. [PMID: 25070077 DOI: 10.1111/jdv.12631] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
10 Vavricka SR, Galván JA, Dawson H, Soltermann A, Biedermann L, Scharl M, Schoepfer AM, Rogler G, Prinz Vavricka MB, Terracciano L, Navarini A, Zlobec I, Lugli A, Greuter T. Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2018;12:347-54. [DOI: 10.1093/ecco-jcc/jjx158] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
11 Maalouf D, Battistella M, Bouaziz J. Neutrophilic dermatosis: disease mechanism and treatment. Current Opinion in Hematology 2015;22:23-9. [DOI: 10.1097/moh.0000000000000100] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 5.2] [Reference Citation Analysis]
12 Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, Meroni PL, Cugno M. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome. Clin Exp Immunol 2014;178:48-56. [PMID: 24903614 DOI: 10.1111/cei.12394] [Cited by in Crossref: 141] [Cited by in F6Publishing: 102] [Article Influence: 20.1] [Reference Citation Analysis]
13 Heath MS, Ortega-Loayza AG. Insights Into the Pathogenesis of Sweet's Syndrome. Front Immunol 2019;10:414. [PMID: 30930894 DOI: 10.3389/fimmu.2019.00414] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
14 Campos TM, Passos ST, Novais FO, Beiting DP, Costa RS, Queiroz A, Mosser D, Scott P, Carvalho EM, Carvalho LP. Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous Leishmaniasis. PLoS Negl Trop Dis 2014;8:e3282. [PMID: 25393535 DOI: 10.1371/journal.pntd.0003282] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
15 Gameiro A, Pereira N, Cardoso JC, Gonçalo M. Pyoderma gangrenosum: challenges and solutions. Clin Cosmet Investig Dermatol 2015;8:285-93. [PMID: 26060412 DOI: 10.2147/CCID.S61202] [Cited by in Crossref: 49] [Cited by in F6Publishing: 13] [Article Influence: 8.2] [Reference Citation Analysis]
16 Garcovich S, De Simone C, Berti E, Marzano AV. Drug management of neutrophilic dermatoses. Expert Rev Clin Pharmacol 2017;10:1119-28. [PMID: 28715916 DOI: 10.1080/17512433.2017.1356719] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
17 Lauridsen HM, Pellowe AS, Ramanathan A, Liu R, Miller-Jensen K, McNiff JM, Pober JS, Gonzalez AL. Tumor Necrosis Factor-α and IL-17A Activation Induces Pericyte-Mediated Basement Membrane Remodeling in Human Neutrophilic Dermatoses. Am J Pathol 2017;187:1893-906. [PMID: 28609645 DOI: 10.1016/j.ajpath.2017.04.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
18 Peroni A, Colato C, Schena D, Rongioletti F, Girolomoni G. Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages. J Am Acad Dermatol 2015;72:131-9. [PMID: 25440433 DOI: 10.1016/j.jaad.2014.09.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
19 Herberger K. [Pyoderma gangrenosum]. Hautarzt 2016;67:753-63. [PMID: 27492434 DOI: 10.1007/s00105-016-3847-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
20 Nazary M, van der Zee HH, Prens EP, Folkerts G, Boer J. Pathogenesis and pharmacotherapy of Hidradenitis suppurativa. Eur J Pharmacol. 2011;672:1-8. [PMID: 21930119 DOI: 10.1016/j.ejphar.2011.08.047] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
21 Marzano AV, Ceccherini I, Gattorno M, Fanoni D, Caroli F, Rusmini M, Grossi A, De Simone C, Borghi OM, Meroni PL, Crosti C, Cugno M. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore) 2014;93:e187. [PMID: 25501066 DOI: 10.1097/MD.0000000000000187] [Cited by in Crossref: 75] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
22 Webb K, Hlela C, Jordaan HF, Suliman S, Scriba T, Lipsker D, Scott C. A Review and Proposed Approach to the Neutrophilic Dermatoses of Childhood. Pediatr Dermatol 2015;32:437-46. [DOI: 10.1111/pde.12502] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
23 Marzano AV, Raimondo MG, Berti E, Meroni PL, Ingegnoli F. Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis. Clin Rev Allergy Immunol 2017;53:428-38. [PMID: 28578472 DOI: 10.1007/s12016-017-8616-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 11.3] [Reference Citation Analysis]
24 Gennero L, De Siena R, Denysenko T, Roos MA, Calisti GF, Martano M, Fiobellot S, Panzone M, Reguzzi S, Gabetti L, Vercelli A, Cavallo G, Ricci E, Pescarmona GP. A novel composition for in vitro and in vivo regeneration of skin and connective tissues. Cell Biochem Funct 2011;29:311-33. [PMID: 21491468 DOI: 10.1002/cbf.1751] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
25 Baroni A, Buommino E, Piccolo V, Chessa MA, Russo T, Cozza V, Ruocco V. Alterations of skin innate immunity in lymphedematous limbs: Correlations with opportunistic diseases. Clinics in Dermatology 2014;32:592-8. [DOI: 10.1016/j.clindermatol.2014.04.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
26 Ohmaru-Nakanishi T, Goto H, Maehara M, Oishi H, Ueoka Y. Perineal pyoderma gangrenosum in pregnancy: A case report. Case Rep Womens Health 2019;22:e00102. [PMID: 30976523 DOI: 10.1016/j.crwh.2019.e00102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Maverakis E, Marzano AV, Le ST, Callen JP, Brüggen M, Guenova E, Dissemond J, Shinkai K, Langan SM. Pyoderma gangrenosum. Nat Rev Dis Primers 2020;6. [DOI: 10.1038/s41572-020-0213-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
28 Weizman AV, Huang B, Targan S, Dubinsky M, Fleshner P, Kaur M, Ippoliti A, Panikkath D, Vasiliauskas E, Shih D. Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study. J Cutan Med Surg. 2015;19:125-131. [PMID: 25775631 DOI: 10.2310/7750.2014.14053] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
29 Bou-Dargham MJ, Khamis ZI, Cognetta AB, Sang QA. The Role of Interleukin-1 in Inflammatory and Malignant Human Skin Diseases and the Rationale for Targeting Interleukin-1 Alpha. Med Res Rev 2017;37:180-216. [PMID: 27604144 DOI: 10.1002/med.21406] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
30 Cugno M, Borghi A, Marzano AV. PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment. Am J Clin Dermatol 2017;18:555-62. [DOI: 10.1007/s40257-017-0265-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 35] [Article Influence: 15.3] [Reference Citation Analysis]
31 Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014;20:213-227. [PMID: 24105394 DOI: 10.1097/01.mib.0000436959.62286.f9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 16] [Article Influence: 9.7] [Reference Citation Analysis]
32 Marzano AV, Vezzoli P, Berti E. Skin involvement in cutaneous and systemic vasculitis. Autoimmunity Reviews 2013;12:467-76. [DOI: 10.1016/j.autrev.2012.08.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 30] [Article Influence: 7.4] [Reference Citation Analysis]
33 Wollina U. Emerging treatments for pyoderma gangrenosum. Expert Opinion on Orphan Drugs 2017;5:827-32. [DOI: 10.1080/21678707.2017.1375404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Al Ghazal P, Herberger K, Schaller J, Strölin A, Hoff NP, Goerge T, Roth H, Rabe E, Karrer S, Renner R. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. Orphanet J Rare Dis. 2013;8:136. [PMID: 24010984 DOI: 10.1186/1750-1172-8-136] [Cited by in Crossref: 76] [Cited by in F6Publishing: 53] [Article Influence: 9.5] [Reference Citation Analysis]
35 Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol. 2017;18:355-372. [PMID: 28224502 DOI: 10.1007/s40257-017-0251-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 58] [Article Influence: 32.7] [Reference Citation Analysis]
36 Marzano AV, Cugno M, Trevisan V, Lazzari R, Fanoni D, Berti E, Crosti C. Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses. Int J Immunopathol Pharmacol 2011;24:451-60. [PMID: 21658319 DOI: 10.1177/039463201102400218] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
37 González-Moreno J, Ruíz-Ruigomez M, Callejas Rubio JL, Ríos Fernández R, Ortego Centeno N. Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature. Lupus 2015;24:130-7. [PMID: 25199808 DOI: 10.1177/0961203314550227] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
38 Plumptre I, Knabel D, Tomecki K. Pyoderma Gangrenosum: A Review for the Gastroenterologist. Inflamm Bowel Dis 2018;24:2510-7. [PMID: 29788368 DOI: 10.1093/ibd/izy174] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
39 Antiga E, Maglie R, Volpi W, Bianchi B, Berti E, Marzano AV, Caproni M. T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum. Clin Exp Immunol 2017;189:383-91. [PMID: 28518224 DOI: 10.1111/cei.12989] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
40 Mckenzie F, Arthur M, Ortega-loayza AG. Pyoderma Gangrenosum: What Do We Know Now? Curr Derm Rep 2018;7:147-57. [DOI: 10.1007/s13671-018-0224-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
41 Sujobert P, Cuccuini W, Vignon-Pennamen D, Martin-Garcia N, Albertini AF, Uzunov M, Redjoul R, Dombret H, Raffoux E. Evidence of differentiation in myeloid malignancies associated neutrophilic dermatosis: a fluorescent in situ hybridization study of 14 patients. J Invest Dermatol 2013;133:1111-4. [PMID: 23190893 DOI: 10.1038/jid.2012.408] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
42 Quaglino P, Fava P, Caproni M, Antiga E, De Simone C, Papini M, Parodi A, Novelli M, Osella-abate S, Ribero S, Sanlorenzo M, Ponti R, Fierro M, Marzano A, Savoia P. Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group. J Eur Acad Dermatol Venereol 2016;30:655-8. [DOI: 10.1111/jdv.13100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
43 Ghonime M, Emara M, Shawky R, Soliman H, El-Domany R, Abdelaziz A. Immunomodulation of RAW 264.7 murine macrophage functions and antioxidant activities of 11 plant extracts. Immunol Invest 2015;44:237-52. [PMID: 25564700 DOI: 10.3109/08820139.2014.988720] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
44 Franco S, Foresta G, Pulvirenti E, Giannone G. Ulcerative colitis complicated by atypical peristomal pyoderma gangrenosum: . Inflammatory Bowel Diseases 2011;17:E111-2. [DOI: 10.1002/ibd.21784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
45 Hobbs MM, Ortega-Loayza AG. Pyoderma gangrenosum: From historical perspectives to emerging investigations. Int Wound J 2020;17:1255-65. [PMID: 32378319 DOI: 10.1111/iwj.13389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
46 Peteln I, Dolenc-Voljč M, Jurčić V. Neutrophilic dermatosis of the dorsal hands (acral Sweet syndrome) with predominantly lymphocytic dermal infiltrate. J Cutan Pathol 2020;47:104-7. [PMID: 31596005 DOI: 10.1111/cup.13589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Prat L, Bouaziz JD, Wallach D, Vignon-Pennamen MD, Bagot M. Neutrophilic dermatoses as systemic diseases. Clin Dermatol 2014;32:376-88. [PMID: 24767185 DOI: 10.1016/j.clindermatol.2013.11.004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 42] [Article Influence: 8.9] [Reference Citation Analysis]
48 Gerber PA, Buhren BA, Steinhoff M, Homey B. Rosacea: The cytokine and chemokine network. J Investig Dermatol Symp Proc 2011;15:40-7. [PMID: 22076326 DOI: 10.1038/jidsymp.2011.9] [Cited by in Crossref: 75] [Cited by in F6Publishing: 56] [Article Influence: 8.3] [Reference Citation Analysis]
49 Dolci A, Indirli R, Genovese G, Derlino F, Arosio M, Marzano AV. Post-surgical Thyroid Bed Pyoderma Gangrenosum Mimicking Recurrent Papillary Thyroid Carcinoma. Front Endocrinol (Lausanne) 2019;10:253. [PMID: 31057489 DOI: 10.3389/fendo.2019.00253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Genovese G, Tavecchio S, Berti E, Rongioletti F, Marzano AV. Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis: two cases and literature review. Rheumatol Int 2018;38:1139-51. [PMID: 29721696 DOI: 10.1007/s00296-018-4035-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
51 Marzano AV, Borghi A, Meroni PL, Cugno M. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol. 2016;175:882-891. [PMID: 27106250 DOI: 10.1111/bjd.14691] [Cited by in Crossref: 84] [Cited by in F6Publishing: 49] [Article Influence: 16.8] [Reference Citation Analysis]
52 Wang EA, Steel A, Luxardi G, Mitra A, Patel F, Cheng MY, Wilken R, Kao J, de Ga K, Sultani H, Merleev AA, Marusina AI, Brassard A, Fung MA, Konia T, Shimoda M, Maverakis E. Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies. Front Immunol 2017;8:1980. [PMID: 29379508 DOI: 10.3389/fimmu.2017.01980] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
53 Ohtsuka M, Yamamoto T. Rare association of pyoderma gangrenosum and palmoplantar pustulosis: a case report and review of the previous works. J Dermatol. 2014;41:732-735. [PMID: 24986043 DOI: 10.1111/1346-8138.12543] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
54 Soutou B, Vignon-Pennamen D, Chosidow O. [Neutrophilic dermatoses]. Rev Med Interne 2011;32:306-13. [PMID: 20933309 DOI: 10.1016/j.revmed.2010.08.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
55 Wu XR, Shen B. Diagnosis and management of parastomal pyoderma gangrenosum. Gastroenterol Rep (Oxf) 2013;1:1-8. [PMID: 24759661 DOI: 10.1093/gastro/got013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
56 Firinu D, Garcia-Larsen V, Manconi PE, Del Giacco SR. SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment. Curr Rheumatol Rep. 2016;18:35. [PMID: 27108452 DOI: 10.1007/s11926-016-0583-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 42] [Article Influence: 18.3] [Reference Citation Analysis]
57 De Simone C, Caldarola G, Scaldaferri F, Petito V, Perino F, Arena V, Papini M, Caproni M, Peris K. Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum. Int J Dermatol 2016;55:e289-94. [PMID: 26917228 DOI: 10.1111/ijd.13212] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
58 Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol. 2012;3:13. [PMID: 22347192 DOI: 10.3389/fphys.2012.00013] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
59 Kridin K, Cohen AD, Amber KT. Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis. Am J Clin Dermatol 2018;19:479-87. [PMID: 29721816 DOI: 10.1007/s40257-018-0356-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 9.7] [Reference Citation Analysis]
60 Marcoval J, Martín-callizo C, Valentí-medina F, Bonfill-ortí M, Martínez-molina L. Sweet syndrome: long-term follow-up of 138 patients. Clin Exp Dermatol 2016;41:741-6. [DOI: 10.1111/ced.12899] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
61 Navarini AA, Satoh TK, French LE. Neutrophilic dermatoses and autoinflammatory diseases with skin involvement—innate immune disorders. Semin Immunopathol 2016;38:45-56. [DOI: 10.1007/s00281-015-0549-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
62 Lebrun D, Robbins A, Hentzien M, Toquet S, Plee J, Durlach A, Bouaziz JD, Bani-Sadr F, Servettaz A. Two case reports of pyoderma gangrenosum and systemic lupus erythematosus: A rare but nonfortuitous association? Medicine (Baltimore) 2018;97:e11933. [PMID: 30142811 DOI: 10.1097/MD.0000000000011933] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Gupta AS, Greiling TM, Ortega-Loayza AG. A systematic review of pyoderma gangrenosum with pulmonary involvement: clinical presentation, diagnosis and management. J Eur Acad Dermatol Venereol 2018;32:e295-7. [PMID: 29377399 DOI: 10.1111/jdv.14828] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
64 Mo W, Wang X, Wang Y, Li Y, Zhang R. Clonal neutrophil infiltrates in concurrent Sweet's syndrome and acute myeloid leukemia: A case report and literature review. Cancer Genet 2018;226-227:11-6. [PMID: 30005849 DOI: 10.1016/j.cancergen.2018.04.120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
65 Sawka E, Zhou A, Latour E, Friedman M, Ortega-Loayza AG. Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review. Clin Rheumatol 2021. [PMID: 34002351 DOI: 10.1007/s10067-021-05768-7] [Reference Citation Analysis]
66 Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013;45:202-210. [PMID: 23334898 DOI: 10.1007/s12016-012-8351-x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 64] [Article Influence: 13.7] [Reference Citation Analysis]
67 Marzano AV, Tavecchio S, Berti E, Gelmetti C, Cugno M. Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients With Inflammatory Bowel Diseases. Medicine (Baltimore) 2015;94:e1818. [PMID: 26559252 DOI: 10.1097/MD.0000000000001818] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 3.4] [Reference Citation Analysis]
68 Kothary V, Doster RS, Rogers LM, Kirk LA, Boyd KL, Romano-Keeler J, Haley KP, Manning SD, Aronoff DM, Gaddy JA. Group B Streptococcus Induces Neutrophil Recruitment to Gestational Tissues and Elaboration of Extracellular Traps and Nutritional Immunity. Front Cell Infect Microbiol 2017;7:19. [PMID: 28217556 DOI: 10.3389/fcimb.2017.00019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
69 Bittencourt MCB, Atanazio MJ, Xavier EM, Costa SF. Postsurgical pyoderma gangrenosum after an autologous stem cell transplantation for multiple myeloma. BMJ Case Rep 2018;2018:bcr-2017-222286. [PMID: 29305364 DOI: 10.1136/bcr-2017-222286] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Moran B, Sweeney CM, Hughes R, Malara A, Kirthi S, Tobin AM, Kirby B, Fletcher JM. Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy. J Invest Dermatol 2017;137:2389-95. [PMID: 28652108 DOI: 10.1016/j.jid.2017.05.033] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 19.3] [Reference Citation Analysis]
71 Thornburg DA, Aime V, James S, Gupta N, Bernard R, Johnson ML. Pyoderma Gangrenosum: A Rare Disease With Dire Consequences in Facial Aesthetic Surgery Patients. Aesthet Surg J 2021;41:NP709-16. [PMID: 33471065 DOI: 10.1093/asj/sjab026] [Reference Citation Analysis]
72 Solovan C, Smiszek R, Wickenhauser C, Chiticariu E. Postoperative pyoderma gangrenosum in association with renal cell carcinoma and chronic lymphocytic leukemia. Infect Dis Ther 2013;2:75-80. [PMID: 25135825 DOI: 10.1007/s40121-013-0008-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Steele RB, Nugent WH, Braswell SF, Frisch S, Ferrell J, Ortega-Loayza AG. Pyoderma gangrenosum and pregnancy: an example of abnormal inflammation and challenging treatment. Br J Dermatol 2016;174:77-87. [PMID: 26474193 DOI: 10.1111/bjd.14230] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
74 Wu BC, Patel ED, Ortega-Loayza AG. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum. Br J Dermatol 2017;177:72-83. [PMID: 27864925 DOI: 10.1111/bjd.15193] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
75 Pukar C, Sudha A, Punam P. Simultaneous occurrence of Pyoderma Gangrenosum and Palmoplantar Pustular Psoriasis: Is it an association or coincidental findings? Clin Case Rep 2021;9:410-5. [PMID: 33489191 DOI: 10.1002/ccr3.3544] [Reference Citation Analysis]
76 Coondoo A. The role of cytokines in the pathomechanism of cutaneous disorders. Indian J Dermatol 2012;57:90-6. [PMID: 22615502 DOI: 10.4103/0019-5154.94272] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
77 Uchino M, Ikeuchi H, Matsuoka H, Bando T, Takahashi Y, Takesue Y, Matsumoto T, Tomita N. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease. Digestion. 2012;85:295-301. [PMID: 22584791 DOI: 10.1159/000336719] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
78 Pink A, Anzengruber F, Navarini A. Acne and hidradenitis suppurativa. Br J Dermatol 2018;178:619-31. [DOI: 10.1111/bjd.16231] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
79 Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol. 2015;73:691-698. [PMID: 26253362 DOI: 10.1016/j.jaad.2015.06.021] [Cited by in Crossref: 116] [Cited by in F6Publishing: 73] [Article Influence: 19.3] [Reference Citation Analysis]
80 Marzano AV, Tavecchio S, Berti E, Gelmetti C, Cugno M. Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for Autoinflammation. Medicine (Baltimore) 2015;94:e2301. [PMID: 26683967 DOI: 10.1097/MD.0000000000002301] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
81 Yamamoto T. Pyoderma gangrenosum: An important dermatologic condition occasionally associated with rheumatic diseases. WJR 2015;5:101. [DOI: 10.5499/wjr.v5.i2.101] [Cited by in CrossRef: 3] [Article Influence: 0.5] [Reference Citation Analysis]
82 Caproni M, Antiga E, Volpi W, Verdelli A, Venegoni L, Quaglino P, Fabbri P, Marzano A. The Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum. Br J Dermatol 2015;173:275-8. [DOI: 10.1111/bjd.13670] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
83 Nelson CA, Stephen S, Ashchyan HJ, James WD, Micheletti RG, Rosenbach M. Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease. J Am Acad Dermatol 2018;79:987-1006. [PMID: 29653210 DOI: 10.1016/j.jaad.2017.11.064] [Cited by in Crossref: 57] [Cited by in F6Publishing: 29] [Article Influence: 19.0] [Reference Citation Analysis]
84 Jiang YY, Li J, Li Y, Wang Q, Liu S, Fang K, Qian JM, Jin HZ. Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum. Chin Med J (Engl) 2017;130:2674-9. [PMID: 29133754 DOI: 10.4103/0366-6999.218004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
85 Marzano AV, Ortega-Loayza AG, Heath M, Morse D, Genovese G, Cugno M. Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases. Front Immunol 2019;10:1059. [PMID: 31139187 DOI: 10.3389/fimmu.2019.01059] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 15.0] [Reference Citation Analysis]
86 Marzano AV, Borghi A, Wallach D, Cugno M. A Comprehensive Review of Neutrophilic Diseases. Clinic Rev Allerg Immunol 2018;54:114-30. [DOI: 10.1007/s12016-017-8621-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 38] [Article Influence: 15.8] [Reference Citation Analysis]